| 2024 |
| 02/01 | 16:30 行使価額修正条項付新株予約権の月間行使状況に関するお知らせ |
| 01/30 | 540 | 572 | 529 | 562 | +3.69% | 1,252,900 | 376億1421万 | -12.73% |
| 01/29 | 561 | 577 | 538 | 542 | -5.08% | 1,995,800 | 362億7562万 | -16.74% |
| 01/26 | 561 | 583 | 535 | 571 | +9.6% | 4,424,900 | 382億1657万 | -13.09% |
| 01/25 | 18:00 国内SB623慢性期外傷性脳損傷プログラム製造販売承認取得の状況について(続報) |
| 01/25 | 495 | 528 | 487 | 521 | +5.04% | 1,132,600 | 348億7011万 | -20.94% |
| 01/24 | 506 | 516 | 488 | 496 | -1.78% | 1,558,700 | 331億9688万 | -24.96% |
| 01/23 | 521 | 539 | 504 | 505 | -4.9% | 2,960,800 | 337億9924万 | -23.48% |
| 01/22 | 631 | 645 | 531 | 531 | -15.85% | 1,024,600 | 347億8501万 | -19.42% |
| 01/19 | 609 | 636 | 605 | 631 | +4.3% | 674,400 | 413億3586万 | -3.81% |
| 01/18 | 615 | 619 | 600 | 605 | -2.73% | 834,100 | 396億3264万 | -6.92% |
| 01/17 | 650 | 650 | 617 | 622 | -4.75% | 1,071,700 | 407億4628万 | -3.72% |
| 01/16 | 650 | 659 | 642 | 653 | +0.46% | 698,800 | 427億7705万 | +1.87% |
| 01/15 | 686 | 688 | 640 | 650 | -5.11% | 1,727,200 | 425億8052万 | +2.2% |
| 01/12 | 703 | 708 | 683 | 685 | -3.25% | 850,800 | 448億7332万 | +8.73% |
| 01/11 | 702 | 715 | 692 | 708 | +0.43% | 765,900 | 463億8001万 | +13.64% |
| 01/10 | 707 | 724 | 695 | 705 | -1.26% | 937,800 | 461億8349万 | +14.63% |
| 01/09 | 16:30 行使価額修正条項付新株予約権の大量行使に関するお知らせ |
| 01/09 | 15:00 ストック・オプション(新株予約権)の取得・消却に関するお知らせ |
| 01/09 | 752 | 753 | 707 | 714 | -4.8% | 1,655,700 | 467億7307万 | +17.63% |
| 01/05 | 777 | 779 | 742 | 750 | -2.72% | 2,205,000 | 491億3137万 | +25% |
| 01/04 | 16:30 行使価額修正条項付新株予約権の月間行使状況に関するお知らせ |
| 01/04 | 732 | 771 | 709 | 771 | +9.83% | 2,901,300 | 505億705万 | +30.68% |
| 2023 |
| 12/29 | 701 | 703 | 681 | 702 | -0.14% | 1,011,800 | 459億8696万 | +21.03% |
| 12/28 | 699 | 720 | 690 | 703 | -1.95% | 1,380,000 | 460億5247万 | +22.47% |
| 12/27 | 654 | 728 | 648 | 717 | +9.63% | 2,366,900 | 469億6959万 | +26.9% |
| 12/26 | 675 | 684 | 652 | 654 | -2.39% | 1,021,100 | 428億4256万 | +17.63% |
| 12/25 | 709 | 724 | 666 | 670 | -7.2% | 1,638,600 | 438億9069万 | +22.04% |
| 12/22 | 729 | 748 | 703 | 722 | +0.98% | 2,737,400 | 472億9713万 | +33.46% |
| 12/21 | 16:30 行使価額修正条項付新株予約権の大量行使に関するお知らせ |
| 12/21 | 743 | 756 | 691 | 715 | -2.72% | 3,653,400 | 468億3857万 | +34.91% |
| 12/20 | 714 | 742 | 686 | 735 | +7.93% | 4,137,400 | 481億4874万 | +41.35% |
| 12/19 | 616 | 686 | 609 | 681 | +7.08% | 3,669,300 | 446億1128万 | +34.06% |
| 12/18 | 626 | 649 | 583 | 636 | +14.39% | 5,417,400 | 416億6340万 | +27.71% |
| 12/15 | 556 | 556 | 556 | 556 | +16.81% | 320,300 | 364億2272万 | +13.24% |
| 12/14 | 15:00 海外連結子会社における人員削減等の合理化の結果に関するお知らせ |
| 12/14 | 15:00 国内SB623慢性期外傷性脳損傷プログラム製造販売承認取得の状況について(続報) |
| 12/14 | 15:00 連結子会社による固定資産の譲渡及び特別利益の計上に関するお知らせ |
| 12/14 | 15:00 営業外収益、特別利益及び法人税等調整額の計上に関するお知らせ |
| 12/14 | 15:00 2024年1月期第3四半期決算短信〔日本基準〕(連結) |
| 12/14 | 480 | 487 | 467 | 476 | +0.85% | 549,300 | 311億8204万 | -2.26% |
| 12/13 | 465 | 475 | 458 | 472 | +0.43% | 322,400 | 309億2001万 | -2.88% |
| 12/12 | 483 | 489 | 466 | 470 | -4.08% | 595,700 | 307億8899万 | -3.29% |
| 12/11 | 490 | 500 | 488 | 490 | -1.41% | 305,300 | 320億9916万 | +0.62% |
| 12/08 | 489 | 499 | 486 | 497 | 0% | 307,500 | 325億5772万 | +2.47% |
| 12/07 | 518 | 520 | 496 | 497 | -4.05% | 411,000 | 325億5772万 | +3.11% |
| 12/06 | 512 | 522 | 506 | 518 | +2.57% | 374,400 | 339億3340万 | +8.14% |
| 12/05 | 517 | 519 | 504 | 505 | -2.32% | 280,600 | 330億8179万 | +6.32% |
| 12/04 | 515 | 527 | 508 | 517 | +2.38% | 379,300 | 338億6789万 | +9.53% |
| 12/01 | 515 | 516 | 497 | 505 | -1.75% | 369,400 | 330億8179万 | +7.68% |
| 11/30 | 516 | 520 | 504 | 514 | -0.39% | 297,500 | 336億7137万 | +9.83% |
| 11/29 | 517 | 546 | 515 | 516 | -0.19% | 580,300 | 338億238万 | +10.26% |
| 11/28 | 518 | 528 | 509 | 517 | -1.71% | 435,700 | 338億6789万 | +10% |
| 11/27 | 563 | 565 | 515 | 526 | -3.84% | 1,320,600 | 344億5747万 | +11.21% |
| 11/24 | 481 | 550 | 481 | 547 | +13.72% | 1,948,300 | 358億3315万 | +14.68% |
| 11/22 | 486 | 487 | 475 | 481 | -0.21% | 390,100 | 315億958万 | +0.42% |
| 11/21 | 488 | 488 | 475 | 482 | 0% | 357,000 | 315億7509万 | -0.21% |
| 11/20 | 470 | 482 | 464 | 482 | +3.88% | 546,300 | 315億7509万 | -1.23% |
| 11/17 | 446 | 466 | 444 | 464 | +2.2% | 292,900 | 303億9594万 | -5.69% |
| 11/16 | 450 | 454 | 444 | 454 | -0.44% | 270,000 | 297億4085万 | -8.84% |
| 11/15 | 443 | 460 | 443 | 456 | +4.83% | 473,200 | 298億7187万 | -9.52% |
| 11/14 | 447 | 450 | 433 | 435 | -1.36% | 325,800 | 284億9619万 | -14.87% |
| 11/13 | 450 | 455 | 440 | 441 | -2.65% | 364,600 | 288億8924万 | -14.86% |
| 11/10 | 453 | 458 | 448 | 453 | -2.58% | 345,000 | 296億7535万 | -13.38% |
| 11/09 | 458 | 471 | 453 | 465 | +1.53% | 284,100 | 304億6145万 | -11.93% |
| 11/08 | 472 | 476 | 453 | 458 | -2.14% | 515,800 | 300億289万 | -14.07% |
| 11/07 | 461 | 474 | 451 | 468 | -1.47% | 608,500 | 306億5797万 | -13.17% |
| 11/06 | 469 | 478 | 458 | 475 | +4.17% | 780,100 | 311億1653万 | -13% |
| 11/02 | 420 | 458 | 417 | 456 | +9.35% | 936,900 | 298億7187万 | -17.39% |
| 11/01 | 421 | 424 | 408 | 417 | -0.48% | 547,200 | 273億1704万 | -25.4% |
| 10/31 | 418 | 428 | 416 | 419 | +0.24% | 489,800 | 274億4806万 | -26.23% |
| 10/30 | 431 | 438 | 416 | 418 | -4.13% | 788,400 | 273億8255万 | -27.56% |
| 10/27 | 447 | 451 | 435 | 436 | -2.46% | 783,000 | 285億6170万 | -25.72% |
| 10/26 | 468 | 468 | 437 | 447 | -7.64% | 1,752,000 | 292億8230万 | -24.87% |
| 10/25 | 501 | 508 | 483 | 484 | -1.43% | 1,119,700 | 317億611万 | -20% |
| 10/24 | 484 | 495 | 484 | 491 | -15.92% | 1,719,500 | 321億6467万 | -20.03% |
| 10/23 | 599 | 603 | 581 | 584 | -2.18% | 375,100 | 379億3506万 | -6.11% |
| 10/20 | 600 | 603 | 589 | 597 | -1.16% | 327,900 | 387億7950万 | -4.48% |
| 10/19 | 592 | 605 | 591 | 604 | +1% | 270,300 | 392億3421万 | -3.67% |
| 10/18 | 594 | 604 | 589 | 598 | +0.84% | 249,100 | 388億4446万 | -4.78% |
| 10/17 | 598 | 607 | 589 | 593 | -0.67% | 290,600 | 385億1968万 | -5.87% |
| 10/16 | 597 | 598 | 587 | 597 | +0.17% | 260,500 | 387億7950万 | -5.54% |
| 10/13 | 608 | 610 | 593 | 596 | -2.93% | 330,300 | 387億1455万 | -5.85% |
| 10/12 | 612 | 622 | 606 | 614 | +1.32% | 200,800 | 398億8378万 | -3.61% |
| 10/11 | 623 | 623 | 604 | 606 | -2.42% | 304,100 | 393億6412万 | -5.61% |
| 10/10 | 611 | 626 | 604 | 621 | +2.48% | 360,300 | 403億3848万 | -3.42% |
| 10/06 | 587 | 606 | 583 | 606 | +3.95% | 306,700 | 393億6412万 | -5.75% |
| 10/05 | 580 | 593 | 575 | 583 | +2.1% | 308,700 | 378億7010万 | -9.19% |
| 10/04 | 590 | 599 | 571 | 571 | -4.36% | 559,800 | 370億9061万 | -11.06% |
| 10/03 | 606 | 626 | 594 | 597 | -1.97% | 462,900 | 387億7950万 | -7.01% |
| 10/02 | 16:30 行使価額修正条項付新株予約権の月間行使状況に関するお知らせ |
| 10/02 | 635 | 635 | 605 | 609 | -2.72% | 380,200 | 395億5899万 | -5.14% |
| 09/29 | 631 | 643 | 623 | 626 | -0.79% | 320,400 | 406億6327万 | -2.19% |
| 09/28 | 634 | 639 | 628 | 631 | -1.1% | 237,900 | 409億8805万 | -1.1% |
| 09/27 | 622 | 639 | 619 | 638 | +1.92% | 378,700 | 414億4275万 | +0.31% |
| 09/26 | 645 | 645 | 622 | 626 | -3.84% | 480,700 | 406億6327万 | -1.26% |
| 09/25 | 670 | 673 | 647 | 651 | -1.81% | 397,600 | 422億8720万 | +3.17% |
| 09/22 | 657 | 668 | 647 | 663 | +2.31% | 393,300 | 430億6669万 | +5.74% |
| 09/21 | 680 | 681 | 643 | 648 | -5.95% | 805,900 | 420億9207万 | +4.18% |
| 09/20 | 694 | 722 | 687 | 689 | -2.27% | 624,200 | 447億5530万 | +11.49% |
| 09/19 | 707 | 740 | 693 | 705 | 0% | 1,688,800 | 457億9461万 | +15.01% |
| 09/15 | 15:00 2024年1月期第2四半期決算説明会資料 |
| 09/15 | 667 | 710 | 663 | 705 | +8.96% | 2,045,400 | 457億9461万 | +15.95% |
| 09/14 | 15:00 2024年1月期第2四半期累計期間の連結業績予想と実績値との差異に関するお知らせ |
| 09/14 | 15:00 営業外収益及び法人税等調整額の計上に関するお知らせ |
| 09/14 | 15:00 2024年1月期第2四半期決算短信〔日本基準〕(連結) |
| 09/14 | 643 | 651 | 635 | 647 | -0.31% | 406,400 | 420億2711万 | +7.48% |
| 09/13 | 637 | 649 | 635 | 649 | +0.93% | 323,500 | 421億5702万 | +8.35% |
| 09/12 | 629 | 652 | 628 | 643 | +2.23% | 455,100 | 417億6728万 | +7.89% |
| 09/11 | 648 | 648 | 627 | 629 | -2.93% | 549,000 | 408億5789万 | +6.07% |
| 09/08 | 634 | 649 | 628 | 648 | +2.37% | 605,500 | 420億9207万 | +9.64% |
| 09/07 | 650 | 652 | 621 | 633 | -8.26% | 1,681,600 | 411億1771万 | +7.65% |
| 09/06 | 743 | 743 | 686 | 690 | -4.7% | 2,985,600 | 448億2026万 | +17.55% |
| 09/05 | 654 | 729 | 654 | 724 | +11.38% | 3,928,500 | 470億2879万 | +23.97% |
| 09/04 | 632 | 658 | 611 | 650 | +5.01% | 1,866,700 | 422億2198万 | +12.26% |
| 09/01 | 610 | 636 | 604 | 619 | +9.75% | 3,253,000 | 402億832万 | +7.28% |
| 08/31 | 15:00 国内SB623慢性期外傷性脳損傷プログラム製造販売承認取得の状況について(続報) |
